Manuel Hidalgo, M.D., Ph.D. is a Professor of Medicine and Clinical Director of the Gastrointestinal Cancer Center at New York University. Dr. Hidalgo received his M.D. degree from the University of Navarra in Pamplona and a Ph.D. degree from University Autonoma of Madrid. He trained in medicine and medical oncology at Hospital ¨12 de Octubre¨ in Madrid and at the University of Texas Health Science Center in San Antonio where he completed a fellowship program in anticancer drug development. He is a member of Bristol Myers Squibb and Guardant Health Board of Directors and also serves as a Board Member of the American Association for Cancer Research. His main focus of research is in drug development and pancreatic cancer. His group popularized the used of Avatar mouse models for cancer research and has contributed to the development multiple new anticancer agents.